1. Home
  2. VTEX vs ORGO Comparison

VTEX vs ORGO Comparison

Compare VTEX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$4.04

Market Cap

697.3M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.60

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
ORGO
Founded
1999
1985
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.3M
348.6M
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
VTEX
ORGO
Price
$4.04
$2.60
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$5.97
$8.50
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
0.15
Revenue
N/A
$564,169,000.00
Revenue This Year
$12.72
N/A
Revenue Next Year
$9.83
$26.27
P/E Ratio
$43.33
$16.73
Revenue Growth
N/A
17.04
52 Week Low
$2.84
$2.21
52 Week High
$6.82
$7.08

Technical Indicators

Market Signals
Indicator
VTEX
ORGO
Relative Strength Index (RSI) 57.02 51.11
Support Level $3.92 $2.26
Resistance Level $4.21 $5.08
Average True Range (ATR) 0.15 0.16
MACD -0.01 0.08
Stochastic Oscillator 53.57 90.71

Price Performance

Historical Comparison
VTEX
ORGO

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: